| | |
|
        | |
  | |
|
| Investors Home | Management Team | Board of Directors | Events Calendar | SEC Filings | Financial Statements | FAQ | |
| | | |
|  | |  |
| | | |
| | | |
| | | |
| | |
Download Corporate Profile  2005 Letter to Stockholders
|
|
ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs.
We apply new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identify proprietary and related molecules for better patient treatment. Investor Relations Contact: Suzanne McKenna (646) 214-0703 ir@ziopharm.com |
|
Please visit the OTC Bulletin Board for the latest ZIOP stock quote: http://www.otcbb.com/asp/Info_Center.asp?symbol=ziop Transfer Agent: American Stock Transfer and Trust 1601 15th Avenue New York, NY 11219 877-248-6417 | | |
  Businessweek article July 23, 2007 issue More Businessweek article May 5, 2008 issue More Forbes.com article May 9, 2008 issue More ZIO-101 listed as 100 Great Investigational Drugs by R&D Directions More ZIO-201 listed as 100 Great Investigational Drugs by R&D Directions More  Robert W. Baird 2006 Focus on Oncology Conference August 2, 2006 New York, NY Click here for Webcast Click here for Presentation Wall Street Analyst Forum June 14, 2006 New York, NY Click here for Webcast Click here for Presentation ASCO June 2-6, 2006 Atlanta, GA Click here for Presentation Information Request  Investor Kit  Click to receive news alerts |
|
©2005 ZIOPHARM Oncology, Inc. | Privacy Policy |